Bristol-Myers Squibb Company
SUBSTITUTED ISOQUIONLINE DERIVATIVES AS IMMUNOMUDULATORS

Abstract:

The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various pp diseases, including cancer and infectious diseases. (I) ##STR00001##